(23 days)
Not Found
No
The device description and performance studies focus on biological indicators and sterilization monitoring, with no mention of AI or ML technologies.
No
This device is a biological indicator kit used to monitor the effectiveness of a sterilization system, not to directly treat or diagnose a medical condition.
No.
This device is a biological indicator kit used to monitor the effectiveness of a sterilization system, not to diagnose a medical condition in a patient.
No
The device description explicitly states the product contains physical components like chromatography strips, sterile tubes of media, and a transfer loop, which are hardware.
Based on the provided text, the SPOR-TEST PA Biological Indicator Kit is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it's used to "monitor the Steris System 1 liquid chemical sterilization system". This monitoring is done by testing the effectiveness of the sterilization process, which involves analyzing a sample (the biological indicator) in vitro (outside of the body).
- Device Description: The description details the components used for this in vitro analysis: chromatography strips inoculated with spores, sterile culture media, and a transfer loop. These are all tools for performing a biological test in a laboratory-like setting.
- Mechanism: The core function is to determine if the sterilization process successfully killed the spores on the strip. This is achieved by incubating the strip in culture media and observing for growth, which is a classic in vitro diagnostic method.
While the device doesn't directly diagnose a disease in a patient, it diagnoses the effectiveness of a sterilization process, which is a critical step in preventing the spread of disease. This falls under the scope of in vitro diagnostics as defined by regulatory bodies.
N/A
Intended Use / Indications for Use
The SPOR-TEST PA Biological Indicator Kit is only intended to monitor the Steris System 1 liquid chemical sterilization system, with the Steris 20 sterilant. Use in monitoring other sterilization processes is contraindicated.
SPOR-TEST PA Biological Indicators are qualified using Getinge Culture Media. When tested at 1,000 ppm peracetic acid, 50°C, the SPOR-TEST PA Biological Indicator will survive at 41 seconds and will be killed at 6 minutes.
Product codes (comma separated list FDA assigned to the subject device)
FRC
Device Description
The SPOR-TEST PA Biological Indicator Kit is exclusively intended to monitor the Steries System 1 The SPOR-IEST PA Bloogical Indication At is oxcidently interior contains chromatography and sterilization process, with Steris 20 sterilant. The product negations of 40 peracetic aclu stemization process, with Geobacillus spores at a nominal population of 10 strips that are inoculated with Geobacillus stearothermophilus spores at a licenstic stifps that are inoculated with Geobacilias stearomerified soybean casein digest broth) and a fransfer per strip. Stehle lubes of Gellige Media (modifical manner as the Steris® Process Biological Indicator Kit.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Samples from a minimum of 3 different lots of SPOR-TEST PA were tested according to the Samples Trom a Thinhum of S uncrent loto '6r or Srtended to Monitor Sterilizers Used in Health Premittted Notifications for brokers and FDA Reviewers Appendix H. Results provided greater Care Facilities, Drait Guidanee for Masting time for all lots tested per CDRH Guidelines.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Castle® SPOR-TEST PA Biological Indicator Kit (K020205)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.2800 Sterilization process indicator.
(a)
Biological sterilization process indicator —(1)Identification. A biological sterilization process indicator is a device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor adequacy of sterilization. The device consists of a known number of microorganisms, of known resistance to the mode of sterilization, in or on a carrier and enclosed in a protective package. Subsequent growth or failure of the microorganisms to grow under suitable conditions indicates the adequacy of sterilization.(2)
Classification. Class II (performance standards).(b)
Physical/chemical sterilization process indicator —(1)Identification. A physical/chemical sterilization process indicator is a device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor one or more parameters of the sterilization process. The adequacy of the sterilization conditions as measured by these parameters is indicated by a visible change in the device.(2)
Classification. Class II (performance standards).
0
Getinge USA, Inc.
APR 7 -2005 SPOR-TEST PA Bilogical Indicator Kit
Attachment 4 510(k) Summary
Prepared on February 7, 2005
| Submitter: | Getinge USA, Inc.
1777 East Henrietta Rd.
Rochester, NY 14623 USA |
|-------------------|--------------------------------------------------------------------------------------------------|
| Contact Person: | Barb Smith, Operations Manager Consumable Products
Telephone: 585-214-6005 FAX: 585-272-5271 |
| Trade Name: | SPOR-TEST PA Biological Indicator Kit |
| Classification: | Biological Sterilization Process Indicator – 21 CFR 880.2800 (a) Class II |
| Predicate Device: | Castle® SPOR-TEST PA Biological Indicator Kit |
Device Description:
The SPOR-TEST PA Biological Indicator Kit is exclusively intended to monitor the Steries System 1 The SPOR-IEST PA Bloogical Indication At is oxcidently interior contains chromatography
and sterilization process, with Steris 20 sterilant. The product negations of 40 peracetic aclu stemization process, with Geobacillus spores at a nominal population of 10
strips that are inoculated with Geobacillus stearothermophilus spores at a licenstic stifps that are inoculated with Geobacilias stearomerified soybean casein digest broth) and a fransfer per strip. Stehle lubes of Gellige Media (modifical manner as the Steris® Process Biological Indicator Kit.
Intended Use:
The SPOR-TEST PA Biological Indicator Kit is only intended to monitor the Steris System 1 liguid The SPOR-TEST FA Blooglear Indicator Title only Internationing other sterilization processes is
chemical sterilization system, with Steris 20 sterilant. Use in monitoring oth Chemical Stehlization System, with Oteno Eventual Second Getinge Culture Media.
contraindicated. SPOR-TEST PA Biological Indicators are qualified using Getinge Cul Contraindicated. SPOR-TEST TTT Biological Indicators and States PA Biological Indicator will survive at 41 seconds and will be killed at 6 minutes.
Comparison to Unmodified Device:
The SPOR-TEST PA Biological Indicator Kit's manufacturing material, manufacturing methods and The SPOR-TEST PA Diological Indicator TR. STREET PA Biological Indicator Kit (K020205). The storage concilions are the same as the Sacks or 3 days (72 hours) to 2 days (48 hours). Testing per in the in only change is to reduce the mododion time intended to Monitor Sterilizers Used in Health
Premarket Notifications [510(k)] for Biological indicators Intended to Monitor Steri Premaired Notifcations [310(k)] for Blogical Hundton Microsoft H found greater than 97% assurance for a 48 hour readout.
Description of Testing:
Samples from a minimum of 3 different lots of SPOR-TEST PA were tested according to the Samples Trom a Thinhum of S uncrent loto '6r or Srtended to Monitor Sterilizers Used in Health Premailted Notifications for brokers and FDA Reviewers Appendix H. Results provided greater Care Facilities, Drait Guidanee for Masting time for all lots tested per CDRH Guidelines.
Conclusion:
The SPOR-TEST PA Biological Indicator Kit is equivalent to the Castle SPOR-TEST PA Biological THE SI OR-1 LOT TTA Blogiour manaker is System 1 peracetic acid sterilization process with Steris 20 Sterilant with the improvement of results available in 48 hours.
16
1
Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of a human figure with outstretched arms, symbolizing care and protection. The figure is surrounded by a circular border containing the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in capital letters.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 7 2005
Ms. Barb Smith Operations Manager Getingc USA, Incorporated 1777 East Henrietta Road Rochester, New Jersey 14623-3133
Re: K050664
K050004
Trade/Device Name: SPOR-TEST PA Biological Indicator Kit Regulation Number: 880.2800 Regulation Name: Sterilization Process Indicator Regulatory Class: II Product Code: FRC Dated: March 11, 2005 Received: March 15, 2005
Dear Ms. Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device We have reviewed your Section 910(t) promised is substantially equivalent (for the referenced above and have determined the do receile marketed predicate devices marketed in
indications for use stated in the enclosure) to legally marketed predicate and indications for use stated in the chelosarof to togally as and of the Medical Device interstate commerce prior to May 20, 1 7 7 0, the end environment with the provisions of
Amendments, or to devices that have been recordance epprovel of a premarket Amendments, or to devices that have been fees and require approval of a premarket
the Federal Food, Drug, and Cosmetic Act (Act that dout subject to the general the Federal Food, Drug, and Cosmetic Free (rice, market the device, subject to the general approval application (I MA). Tou may, includes of the Act include controls provisions of the Act. The general of the estably and manufacturing practice, a requirements for anifall regionst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III
n affect If your device is classified (see above) into chirolas Existing major regulations affecting
(PMA), it may be subject to such additional controls. Title 21, Ports 800 to 898 (PMA), it may be subject to such adultional volutions. Title 21, Parts 800 to 898. In
your device can be found in the Code of Federal Regulations, Title 21, The Federal your device can be found in the Code of Peachards on the Federal Register.
2
Page 2 - Ms. Smith
Please be advised that FDA's issuance of a substantial equivalence determination does not Please be advised that FDA S Issualice of a substantials with other requirements
mean that FDA has made a determination that your device Fodorol agencies mean that FDA has made a decemination that Journalisms administered by other Federal agencies. of the Act or any rederal statutes and regirements, including, but not limited to: registration in You must comply with an the Act 3 requirements and 01); good manufacturing practice
and listing (21 CFR Part 807); labeling (21 CFR Part 801); gray 830'; and i and listing (21 CFR Part 807), laboling (21 OF North (21 CFR Part 820); and if requirements as set form in the quality systems (Sections 531-542 of the Act);
applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will anow you to begin malicomig your antial equivalence of your device to a premarket notification. The PDA midnig of backanner of your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), a If you desire specific advice for your device at (240) 276-0115. Also, please note the regulation please contact the Office of Comphanes at (210) = 11 = 1 Part 8 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = 1 = entitled, "Ivisoranding by reference to premation on your responsibilities under the Act its tall f may obtain offer general mionmation on your and Consumer Assistance at its toll-free Division of Simal 2011 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Suette H. Michie Oms.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
SPOR-TEST PA Bilogical Indicator Kit
Getinge USA, Inc.
Attachment 2 Indications for Use Statement
510(k) Number: _K050664
Device Name: SPOR-TEST PA Biological Indicator Kit
Indications for Use:
The SPOR-TEST PA Biological Indicator Kit is only intended to monitor the Steris System 1 liquid chemical sterilization system, with the Steris 20 sterilant. Use in monitoring other sterilization processes is contraindicated.
SPOR-TEST PA Biological Indicators are qualified using Getinge Culture Media. When tested at 1,000 ppm peracetic acid, 50°C, the SPOR-TEST PA Biological Indicator will survive at 41 seconds and will be killed at 6 minutes.
Prescription Use (Part 21 CFR 801 Subpart D)
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
: 上一
AND/OR
Over-The-Counter Use X (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Shuli P. Murphy, 152 Hill B 4/7/65
Tision Sign-Off) ivision of Anesthesiology, General Hospital, Intection Control, Dental Devices
K Number: K050464